About
CNS treatments
Areas of Focus
Categories
Biologics & BiopharmaceuticalNon-PharmaceuticalDrug Delivery DeviceUncategorized Medical DeviceAntibody
Team (7)
Anna-Lena Engwall
Anna-Lena EngwallBoard member
BioArctic
team_member
Cecilia Edström
Cecilia EdströmBoard member
BioArctic
team_member
Eugen Steiner
Eugen SteinerChairman of the board
BioArctic
team_member
Lars Lannfelt
Lars LannfeltBoard member
BioArctic
team_member
Lotta Ljungqvist
Lotta LjungqvistBoard member
BioArctic
team_member
Mikael Smedeby
Mikael SmedebyBoard member
BioArctic
team_member
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
46
By Phase
PHASE2: 1PHASE1/PHASE2: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06671938Lead Sponsor
Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy
PHASE2Recruiting
36 participants
Started: Oct 24, 2024 · Completed: Mar 16, 2026
NCT02490501Lead Sponsor
Safety and Efficacy of SC0806 (Fibroblast Growth Factor 1 and a Device) in Traumatic Spinal Cord Injury Subjects
PHASE1/PHASE2Completed
10 participants
Started: Jun 30, 2015 · Completed: May 31, 2025
Locations (1)
Headquarters
Stockholm, Sweden
Map
Loading map...